Thermo Fisher Scientific Inc. introduced the Thermo Scientific DynaSpin Single-Use Centrifuge system to offer the best single-use answer for extensive cell culture collection. Further, by the use of fewer depth filtering cartridges, the DynaSpin technology enhances and streamlines harvesting for cell culture separation in single-use bioprocesses.
PHC Holdings Corporation teamed up with Univercells Technologies to introduce scale-X for gene therapy and regenerative medicine development. Furthermore, the scale-X portfolio provides comparable fluid conditions across all scales, guaranteeing consistent cell and product activity.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4050
Published Date: Apr 25, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising geriatric population and the growing drug development are the major factors driving the market growth.
The market size of cell and tissue culture incubators is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.
High price of incubators and the potential for a critical error are estimated to be the growth-hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are Thermo Fisher Scientific Inc., Bionics Scientific Technologies (P) Ltd., BioSpherix, Ltd, Adolf KÃ¼hner AG, Acmas Technologies Inc., Cole-Parmer Instrument Company, LLC, Sheldon Manufacturing, Inc., and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, application, end-user, and by region.
The IVF Centers segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.